Recommendations for prevention and control of influenza in children, 2019–2020

Yvonne A. Maldonado; Theoklis E. Zaoutis; Ritu Banerjee; Elizabeth D. Barnett; James D. Campbell; Mary T. Caserta; Jeffrey S. Gerber; Athena P. Kourtis; Ruth Lynfield; Flor M. Munoz; Dawn Nolt; Ann Christine Nyquist; Sean T. O’Leary; William J. Steinbach; Ken Zangwill; Henry H. Bernstein; David W. Kimberlin; H. Cody Meissner; Mark H. Sawyer; Stuart T. Weinberg; John M. Kelso; John S. Bradley; Tim Uyeki; Amanda C. Cohn; Tammy R. Beckman; Jamie Deseda-Tous; Karen M. Farizo; Marc Fischer; Natasha B. Halasa; Nicole Le Saux; Scot Moore; Neile S. Silverman; Jeffrey R. Starke; James J. Stevermer; Kay M. Tomashek; Jennifer M. Frantz

doi:10.1542/peds.2019-2478

Recommendations for prevention and control of influenza in children, 2019–2020

Yvonne A. Maldonado, Theoklis E. Zaoutis, Ritu Banerjee, Elizabeth D. Barnett, James D. Campbell, Mary T. Caserta, Jeffrey S. Gerber, Athena P. Kourtis, Ruth Lynfield, Flor M. Munoz, Dawn Nolt, Ann Christine Nyquist, Sean T. O’Leary, William J. Steinbach, Ken Zangwill, Henry H. Bernstein, David W. Kimberlin, H. Cody Meissner, Mark H. Sawyer, Stuart T. WeinbergJohn M. Kelso, John S. Bradley, Tim Uyeki, Amanda C. Cohn, Tammy R. Beckman, Jamie Deseda-Tous, Karen M. Farizo, Marc Fischer, Natasha B. Halasa, Nicole Le Saux, Scot Moore, Neile S. Silverman, Jeffrey R. Starke, James J. Stevermer, Kay M. Tomashek, Jennifer M. Frantz

Pediatrics

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.

Original language	English (US)
Article number	e20192478
Journal	Pediatrics
Volume	144
Issue number	4
DOIs	https://doi.org/10.1542/peds.2019-2478
State	Published - 2019

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2019-2478

Cite this

Maldonado, Y. A., Zaoutis, T. E., Banerjee, R., Barnett, E. D., Campbell, J. D., Caserta, M. T., Gerber, J. S., Kourtis, A. P., Lynfield, R., Munoz, F. M., Nolt, D., Nyquist, A. C., O’Leary, S. T., Steinbach, W. J., Zangwill, K., Bernstein, H. H., Kimberlin, D. W., Meissner, H. C., Sawyer, M. H., ... Frantz, J. M. (2019). Recommendations for prevention and control of influenza in children, 2019–2020. Pediatrics, 144(4), Article e20192478. https://doi.org/10.1542/peds.2019-2478

Maldonado, YA, Zaoutis, TE, Banerjee, R, Barnett, ED, Campbell, JD, Caserta, MT, Gerber, JS, Kourtis, AP, Lynfield, R, Munoz, FM, Nolt, D, Nyquist, AC, O’Leary, ST, Steinbach, WJ, Zangwill, K, Bernstein, HH, Kimberlin, DW, Meissner, HC, Sawyer, MH, Weinberg, ST, Kelso, JM, Bradley, JS, Uyeki, T, Cohn, AC, Beckman, TR, Deseda-Tous, J, Farizo, KM, Fischer, M, Halasa, NB, Le Saux, N, Moore, S, Silverman, NS, Starke, JR, Stevermer, JJ, Tomashek, KM & Frantz, JM 2019, 'Recommendations for prevention and control of influenza in children, 2019–2020', Pediatrics, vol. 144, no. 4, e20192478. https://doi.org/10.1542/peds.2019-2478

@article{3ae2c2c040114f729ef08fb85344abc3,

title = "Recommendations for prevention and control of influenza in children, 2019–2020",

abstract = "This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.",

author = "Maldonado, {Yvonne A.} and Zaoutis, {Theoklis E.} and Ritu Banerjee and Barnett, {Elizabeth D.} and Campbell, {James D.} and Caserta, {Mary T.} and Gerber, {Jeffrey S.} and Kourtis, {Athena P.} and Ruth Lynfield and Munoz, {Flor M.} and Dawn Nolt and Nyquist, {Ann Christine} and O{\textquoteright}Leary, {Sean T.} and Steinbach, {William J.} and Ken Zangwill and Bernstein, {Henry H.} and Kimberlin, {David W.} and Meissner, {H. Cody} and Sawyer, {Mark H.} and Weinberg, {Stuart T.} and Kelso, {John M.} and Bradley, {John S.} and Tim Uyeki and Cohn, {Amanda C.} and Beckman, {Tammy R.} and Jamie Deseda-Tous and Farizo, {Karen M.} and Marc Fischer and Halasa, {Natasha B.} and {Le Saux}, Nicole and Scot Moore and Silverman, {Neile S.} and Starke, {Jeffrey R.} and Stevermer, {James J.} and Tomashek, {Kay M.} and Frantz, {Jennifer M.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2019 by the American Academy of Pediatrics",

year = "2019",

doi = "10.1542/peds.2019-2478",

language = "English (US)",

volume = "144",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "4",

}

TY - JOUR

T1 - Recommendations for prevention and control of influenza in children, 2019–2020

AU - Maldonado, Yvonne A.

AU - Zaoutis, Theoklis E.

AU - Banerjee, Ritu

AU - Barnett, Elizabeth D.

AU - Campbell, James D.

AU - Caserta, Mary T.

AU - Gerber, Jeffrey S.

AU - Kourtis, Athena P.

AU - Lynfield, Ruth

AU - Munoz, Flor M.

AU - Nolt, Dawn

AU - Nyquist, Ann Christine

AU - O’Leary, Sean T.

AU - Steinbach, William J.

AU - Zangwill, Ken

AU - Bernstein, Henry H.

AU - Kimberlin, David W.

AU - Meissner, H. Cody

AU - Sawyer, Mark H.

AU - Weinberg, Stuart T.

AU - Kelso, John M.

AU - Bradley, John S.

AU - Uyeki, Tim

AU - Cohn, Amanda C.

AU - Beckman, Tammy R.

AU - Deseda-Tous, Jamie

AU - Farizo, Karen M.

AU - Fischer, Marc

AU - Halasa, Natasha B.

AU - Le Saux, Nicole

AU - Moore, Scot

AU - Silverman, Neile S.

AU - Starke, Jeffrey R.

AU - Stevermer, James J.

AU - Tomashek, Kay M.

AU - Frantz, Jennifer M.

PY - 2019

Y1 - 2019

N2 - This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.

AB - This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019–2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.

UR - http://www.scopus.com/inward/record.url?scp=85073612882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073612882&partnerID=8YFLogxK

U2 - 10.1542/peds.2019-2478

DO - 10.1542/peds.2019-2478

M3 - Article

C2 - 31477606

AN - SCOPUS:85073612882

SN - 0031-4005

VL - 144

JO - Pediatrics

JF - Pediatrics

IS - 4

M1 - e20192478

ER -

Recommendations for prevention and control of influenza in children, 2019–2020

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this